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Abstract 21 
Gammaherpesviruses are important human and animal pathogens. Infection control has 22 
proved difficult because the key process of transmission is ill-understood. Murid herpesvirus-4 23 
(MuHV-4), a gammaherpesvirus of mice, transmits sexually. We show that this depends on the 24 
major virion envelope glycoprotein, gp150. Gp150 is redundant for host entry and, in vitro, it 25 
regulates rather than promotes cell binding. We show that gp150-deficient MuHV-4 reaches and 26 
replicates normally in the female genital tract after nasal infection, but is poorly released from 27 
vaginal epithelial cells and fails to pass from the female to the male genital tract during sexual 28 
contact. Thus, we show that regulation of virion binding is a key component of spontaneous 29 
gammaherpesvirus transmission. 30 
 31 
 32 
Importance 33 
Gammaherpesviruses are responsible for many important diseases both in animals and 34 
humans. Some important aspects of their lifecycle are still poorly understood. Key amongst these 35 
is viral transmission. Here we show that the major envelope glycoprotein of Murid Herpesvirus 4 36 
functions not in entry or dissemination, but in virion release to allow sexual transmission to new 37 
hosts.  38 
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Introduction 39 
Transmission is the main motor of viral evolution, and the large disease burden imposed 40 
by human gammaherpesviruses reflects very high infection prevalences due to efficient 41 
transmission from carriers to new hosts (1). Epstein-Barr virus (EBV) and the Kaposi's Sarcoma-42 
associated Herpesvirus (KSHV), infect respectively up to 90% (2) and 30% (3) of humans world-43 
wide. Endemic infections are maintained chiefly by carriers shedding virus into their saliva. But 44 
in populations with low infection prevalence, sexual transmission becomes important due to its 45 
increased contact (4). This was seen clearly for the KSHV transmission associated with HIV 46 
infection (5), and may apply also to EBV (6). 47 
While interrupting transmission is the sine qua non of infection control, analyzing EBV 48 
and KSHV transmission has proved difficult. Natural EBV infection is asymptomatic for at least 49 
a month (6) and experimental transmission is made difficult by many EBV and KSHV functions 50 
being host specific. However gammaherpesviruses colonize most mammals, so related animal 51 
viruses, such as Murid gammaherpesvirus 4 (MuHV-4), provide another way to understand 52 
infection in vivo (7). Luciferase imaging of MuHV-4 infection (8), revealed genital infection 53 
following intranasal inoculation of female mice, which then spread to naïve males by sexual 54 
contact (9). This has provided a basis for understanding the molecular determinants of 55 
gammaherpesvirus transmission. 56 
Virion glycoproteins are likely the main actors of transmission. The MuHV-4 envelope 57 
displays at least 10 membrane-bound proteins (10, 11). gH, gB, gM and gN are essential for 58 
infectivity, while gL, gp70, gp150, ORF58, ORF27 and ORF28 are redundant. ORF28 has no 59 
known function (12). ORF27/ORF58 form a complex involved in direct cell to cell viral spread 60 
(13). gM/gN is probably required for virion assembly (14). Gp70, gH/gL and gB all contribute to 61 
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cell binding and/or entry (15, 16). A surprising finding was that gp150 - the MuHV-4 equivalent 62 
of gp350/220 in EBV (17), K8.1A in KSHV (18), and gp180 in Bovine gammaherpesvirus 4 63 
(BoHV-4) (19) - is redundant both for cell binding in vitro and for virion entry into naive hosts 64 
(20). Moreover, gp150-deficient virions show enhanced binding to cells that express little 65 
heparan (20). 66 
Heparan binding is a key event in infection by cell-free MuHV-4 (21), a characteristic 67 
shared by many herpesviruses. MuHV-4 binds to heparan via gH/gL and by gp70 (15, 16). While 68 
heparan is abundant on most transformed stromal cells, the apical surfaces of most differentiated 69 
epithelia display much less. However the lungs and olfactory epithelium, which are efficiently 70 
targeted by MuHV-4, do display heparan. Specifically non-sulfated heparan, which is bound by 71 
gH/gL, is present on the apical cilia of olfactory neurons (22) and on type 1 alveolar epithelial 72 
cells (23). The genital tract is not known to express apical heparan, and here host entry may 73 
depend on sexual contact causing epithelial trauma, which exposes the abundant heparan of 74 
basolateral epithelial surfaces (24). 75 
MuHV-4 also binds to non-heparan ligands, for example via gB (25), but this binding 76 
appears not to be available until heparan is engaged. Thus, virion heparan dependence reflects 77 
both positive and negative regulation. The negative regulation is mediated by gp150, suggesting 78 
that heparan displaces it from covering an important non-heparan binding site (26). The main in 79 
vitro defect of gp150- MuHV-4 is poor release from infected cells, which tend to lose heparan 80 
and are probably coated by the abundantly shed heparan binding domains of gp70 (15, 20). 81 
Gp150 itself binds heparan only weakly, but heparan and gp150 are presumably brought into 82 
close contact by the strong interactions of gH/gL and gp70. The BoHV-4 gp180 also binds to 83 
heparan and regulates heparan-independent virion / cell binding (19). The KSHV K8.1 binds to 84 
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heparan and there have been suggestions of a regulatory role (27, 28). The EBV gp350 does not 85 
bind to heparan(this is a function of the EBV gp150 (29)). However gp350 does regulate binding 86 
to epithelial cells (30), suggesting that it promotes virion release from epithelial cells. Thus, 87 
regulation of cell binding by the major envelope glycoprotein is a common gammaherpesviruses 88 
theme. 89 
Despite the importance of gp150 for MuHV-4 release from infected cells, gp150-deficient 90 
mutants show no defect in host colonization after nasal inoculation (20, 31). This reflects that 91 
host colonization is driven primarily by lymphoproliferation and cell / cell virus transfer (32). 92 
The main function of cell-free virions is viral genome transfer to new hosts. Standard 93 
pathogenesis models ignore this crucial component of the viral life-cycle. Here, we show that 94 
gp150 deficient MuHV-4 has no defect in genital tract colonization but transmits poorly to new 95 
hosts. This reflected poor virion release from the female vaginal epithelium.  96 
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Results 97 
Generation of luciferase+gp150- MuHV-4. Viral luciferase expression is a key tool for 98 
monitoring infection in vivo (8). Thus, to track infection by gp150- MuHV-4, we generated a 99 
luciferase+ version of the previously studied M7-STOP mutant (33) (Fig. 1A). Predicted genomic 100 
structure was confirmed by restriction enzyme digestion and southern blotting of viral DNA 101 
(Fig.1B). Genome sequencing confirmed a lack of mutations elsewhere (data not shown). 102 
Analysis of infected cells confirmed a lack of gp150 expression by gp150- Luc MuHV-4 (Fig. 103 
1C) while expression of other glycoproteins was similar.   104 
 105 
Gp150- MuHV-4 shows no infection defect after intranasal inoculation. Female 106 
BALB/c mice (n=20) were given WT or gp150- Luc MuHV-4 intransally (i.n.) and infection was 107 
tracked by In Vivo Imaging System (IVIS) (Fig.2A). Luminescent signal was observed in nose 108 
and thoracic region at day 7 p.i., and in the neck and left abdominal region at day 14 p.i. (Fig. 2B-109 
C). These signals correspond to lytic infection in the nose, lungs, superficial cervical lymph 110 
nodes (SCLN) and spleen (8). Gp150- MuHV-4 showed greater SCLN signals (p<0.01) but 111 
otherwise there was no difference between the infection groups. 112 
Between days 17 and 21 p.i., the mice were imaged daily to observe the transient genital 113 
signal (9). By this time, primary lytic infection had resolved and the luciferase signals from 114 
lymphoid organs were greatly reduced compared with day 14. Genital luciferase signals were 115 
detectable in 77% of mice given gp150+ MuHV-4 and 64% of those given gp150- MuHV-4 116 
(p>0.05) (Fig. 2D). The maximum intensity of genital signal showed no difference between 117 
groups (p>0.05) (Fig. 2E), nor did the viral DNA loads of luciferase positive vaginal mucosa 118 
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samples (Fig.2F). Thus, gp150- MuHV-4 showed no defect in genital colonization after i.n. 119 
inoculation. 120 
At one month p.i., sera were assayed for MuHV-4 specific IgG by ELISA (Fig. 3A). No 121 
difference was observed between gp150+ and gp150- infections (p>0.05). At the same time 122 
qPCR of spleen DNA showed no gp150+/gp150- difference in viral genome load (Fig. 3B-C). 123 
Thus, gp150- MuHV-4 showed no defect in extent of infection or capacity to establish latency in 124 
the spleen. 125 
 126 
Gp150 promotes sexual transmission from female to male after intranasal infection. 127 
To assay transmission, intranasally infected female BALB/c mice were mated with BALB/c 128 
males at the time of appearance of genital signal (between days 17 and 21 p.i.), mixing 3 naive 129 
males with 3 excreting females (Fig. 4A). In total in 2 independent experiments, 34 males were 130 
mated with gp150+ infected females, and 30 males with gp150- infected females. Males were 131 
imaged every 3-4 days over 3 weeks. 32% of males (n=11) in the gp150+ group showed genital 132 
signal, and 3% (n=1) in the gp150- group (Fig. 4B). Fig. 4C shows the maximal male genital 133 
signals measured between days 7 and 17 post-contact in 1 experiment. 134 
At 1 month post-contact, serum and spleen were collected from males to confirm the 135 
results of in vivo imaging. MuHV-4 specific antibodies were detected in all the males that had 136 
positive IVIS signals (Fig. 4D shows 1 experiment). The same animals were also positive for 137 
splenic viral DNA by quantitative PCR and reactivatable splenic virus by infectious center assay 138 
(Fig. 4E-F). Thus, gp150- MuHV-4 showed significantly less female to male transmission than 139 
gp150+.  140 
 141 
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Gp150 does not promote infection of the penile mucosa. We considered that gp150 142 
disruption might reduce transmission by reducing virus entry into the male penile mucosa. To test 143 
this hypothesis, 30 males were anesthetized with isoflurane, and gp150+ or gp150- MuHV-4 (105 144 
PFU in 15µl PBS) put in contact with scraped penile mucosa for 20 minutes. IVIS imaging over 145 
the 8 next days showed 11/15 infected males in each group (Fig. 5). Thus, gp150 was not 146 
required to infect the penile mucosa. 147 
 148 
Gp150 does not promote transmission by protecting against neutralization. 149 
Gp150 is an immuno-dominant glycoprotein and as anti-gp150 antibodies are non-150 
neutralizing helps by its immunogenity to protect virions against neutralization (34). Gp150-151 
specific antibodies additionally promote MuHV-4 entry into IgG Fc receptor+ cells, and its 152 
gp180 homolog in BoHV-4 acts as a protective glycan shield (35). Thus, although MuHV-4-153 
specific antibody responses are relatively weak at 1 month post-infection (36), gp150 could 154 
potentially promote transmission by reducing the impact of antibody. To test this hypothesis, we 155 
first looked for MuHV-4-specific antibodies in vaginal secretions (Fig. 6A). These were present 156 
at low titer in a minority of infected mice with no significant difference between the 2 groups 157 
(p>0.05). We tested also the susceptibility of gp150+ and gp150- virions to neutralization by sera 158 
of mice infected for one month by the same virus (Fig. 6B). No significant difference was 159 
observed (p>0.05), except at one dilution of serum where gp150+ virions were significantly more 160 
neutralized by the homologous serum (p<0.01). Thus, gp150 seemed not to promote transmission 161 
by directly protecting vulnerable epitopes against antibody neutralization.  162 
 163 
Gp150 promotes release of infectious MuHV-4 virions from vaginal mucosa. Gp150 164 
promotes virion release from infected cells in vitro (33). Thus, we considered that gp150- Luc 165 
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virions might be poorly released into vaginal secretions and so be less available for penile 166 
infection. To test this hypothesis, female BALB/c mice were infected intranasally and when 167 
genital luciferase signals were observed, vaginal washouts were collected for plaque assay. To 168 
distinguish cell-free from cell-associated virions, the vaginal washouts were centrifuged at 100 x 169 
g (10 min) to collect cell-associated virions and then at 20,000 x g (90 min) to collect cell-free 170 
virions. The infection groups showed no significant difference in cell-associated infectivity 171 
(p>0.05); but a lack of gp150 significantly reduced cell-free infectivity (p<0.05) (Fig. 7A). We 172 
also compared gp150+ and gp150- virus growth in primary vaginal epithelial cells. While gp150+ 173 
virions were split equally between supernatant and cells at 24h p.i. and then progressively 174 
increased in supernatants, gp150- virions were strongly cell-associated (Fig. 7B). 175 
Staining infected cells for gN  (Fig. 7C) supported the idea of virion retention: staining 176 
fixed - permeabilized cells showed no significant gp150+/gp150- difference (p>0.05), indicating 177 
similar infection, but staining non-permeabilized cells showed significantly more cell surface gN 178 
after gp150- infection (p<0.001) (Fig. 7C-D). Beside increased virus retention at the cell surface, 179 
the increased gN detection could also be consecutive to increased gN cell surface expression in 180 
cells infected with gp150-deficient virus or to an increased epitope access in absence of gp150. 181 
To distinguish between these hypotheses by direct visualization, we performed Transmission 182 
Electronic Microscopy (TEM) of infected vaginal cells. The cells were exposed to gp150+ or 183 
gp150- MuHV-4 (1 PFU / cell), then analyzed by TEM 24h and 48h later. Gp150+ virions never 184 
formed more than a single layer at the infected cell surface. By contrast gp150-deficient virions 185 
formed multiple layers (Fig. 7E). Such aggregates were not observed in viral stocks showing that 186 
virions do not spontaneously aggregate to each other's (data not shown). Thus, gp150- virions 187 
were poorly released from vaginal epithelial cells.  188 
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Discussion 189 
 Viral transmission is a crucial determinant of disease burden. For example spikes in the 190 
diseases caused by Ebola and Avian influenza viruses are associated with increased infection 191 
rates rather than more virulent infections (37, 38). Conversely, while live and killed poliovirus 192 
vaccines both prevent disease, eradication has depended on live vaccine because it more 193 
effectively inhibits transmission (39). For herpesviruses, which are highly prevalent and only 194 
sometimes cause disease, transmission is a key intervention target. However, even established 195 
live-attenuated vaccines that prevent disease are probably insufficient by themselves to prevent 196 
transmission (40). Therefore, it is important to understand this process better. 197 
Herpesvirus transmission has proved hard to replicate in experimental settings, and is 198 
ignored by most standard pathogenesis assays of host colonization / disease after deliberate 199 
inoculation. Murine cytomegalovirus transmits via the upper respiratory tract (41). MuHV-4 also 200 
enters new hosts via the upper respiratory tract (22). However it has not been shown to transmit 201 
spontaneously by this route. This may reflect that most experimental settings favour low 202 
frequency / high penetrance contacts, rather than the high frequency / low penetrance contacts of 203 
natural, endemic virus exchange. Nonetheless sexual contact may be a significant mode of 204 
transmission for many herpesviruses in populations with low infection prevalence (4) as observed 205 
for KSHV (5) and potentially EBV (6) . Gp150 provides the first example of a viral glycoprotein 206 
important for transmission but not for entry or dissemination, because it is important for virion 207 
release. 208 
Escaping infected cells poses a general problem for non-motile pathogens. One solution is 209 
to produce large numbers of infectious particles and cause widespread epithelial destruction. The 210 
modus operandi of herpesviruses, which transmit chronically, at a low level, and for the most part 211 
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without symptoms, seems instead to centre on entry and exit at different sites. For example, entry 212 
at the olfactory epithelium, where there is apical heparan, and exit from the oropharynx, where 213 
heparan is basolateral (22). Sexual transmission seems to go against this paradigm, as entry and 214 
exit then overlap. For MuHV-4, the lack of its key binding target - heparan - on the apical genital 215 
epithelium (42) suggests that tissue trauma is required for host entry. With sexual transmission 216 
this is entirely plausible. Barring too much tissue trauma in the virus donor, their genital epithelia 217 
should then efficiently shed heparan-dependent virions. Indeed, during sexual transmission, the 218 
shedding probably precedes the trauma. Accordingly, a loss of heparan dependence through 219 
gp150 disruption severely compromised MuHV-4 shedding and the subsequent virus 220 
transmission. In the absence of gp150, the newly produced virions likely bind to components 221 
present at the cell surface. Thus, the unknown cell ligand for which gp150 regulates binding 222 
could be cleaved or have a secreted form that could cause virion aggregation and poor release. 223 
The nature of this cellular component will have to be investigated in future. Thus, heparan 224 
dependence is not just a means of virion capture, but a switch that enables virion capture and 225 
release both to be efficient. We envisage that the BoHV-4 gp180, KSHV K8.1A and EBV gp350 226 
also promote transmission by virion release, at both genital and oral mucosal surfaces, in addition 227 
to any roles they have in host entry. 228 
Could virus shedding be targeted by vaccination? We believe this is unlikely to be 229 
achieved by targeting gp150 or its homologs, as they are already highly immunogenic in virus 230 
carriers (34). Gp150-specific antibodies fail to neutralize MuHV-4; their main effect is to 231 
increase infection of cells with low levels of heparan and high levels of IgG Fc receptors (39); 232 
while (monoclonal) antibodies to the EBV gp350 promote epithelial infection (43). In contrast, 233 
the shedding of infectious virus could potentially be reduced by boosting other, subdominant 234 
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antibody specificities in virus carriers (44). This remains to be tested in the transmission model. 235 
The feasibility of this approach is also supported by the fact that gp150 likely does not act as a 236 
glycan shield (Fig. 6B) in contrast with its homologue in BoHV-4 (35).  237 
Altogether, the present study identifies for the first time the importance of a specific 238 
gammaherpesvirus glycoprotein in transmission. Gp150 did this by promoting virion release from 239 
infected vaginal epithelial cells. These results establish a new and important gp150 function that 240 
may well apply also to its homologs in human pathogens.  241 
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Materials and Methods 242 
Animals. BALB/c mice were housed in the University of Liège, department of infectious 243 
diseases, FARAH. The Committee on the Ethics of Animal Experiments of the University of 244 
Liège approved the protocol (Permit Number: 1502).  245 
Female mice were infected intranasally with 104 PFU of MuHV-4 diluted in 30 µl of 246 
sterile PBS, under general anesthesia with isoflurane. For imaging, mice were injected 247 
intraperitoneally with luciferin (60 mg/kg) and imaged 10 minutes later with an IVIS Spectrum 248 
(Caliper Life Sciences). For quantitative comparisons, we used Living Image software (Caliper 249 
Life Sciences) to obtain the average radiance (photons per second per cm2 per steradian) over 250 
each region of interest. Background measured in the right abdominal region was removed from 251 
the measures.  252 
Viruses. All viruses were derived from a MuHV-4 bacterial artificial chromosome (BAC) 253 
(45). We used a mutant expressing firefly luciferase under the control of the M3 promoter (WT 254 
Luc+) (8). The M7 sequence was disrupted via insertion of an oligonucleotide containing stop 255 
codons in all reading frames and an EcoR1 restriction site at an Afe1 site (genomic co-ordinates 256 
69,743, Genbank accession number: af105037.1) (33). We further mutated this virus to obtain 257 
gp150- Luc+ MuHV-4 by insertion of the luciferase coding sequence (8). Briefly, a luciferase 258 
coding sequence under the control of a M3 promoter and followed by a polyadenylation 259 
(poly(A)) signal was inserted in a Mfe1 site (genomic co-ordinates 77,176), between poly(A) 260 
signals of ORF57 and ORF58.  261 
For in vivo experiments, the loxP-flanked BAC/eGFP cassette was removed by virus 262 
growth in NIH-3T3-CRE cells until eGFP+ cells were no longer visible (46). Virus stocks were 263 
grown in BHK-21 cells cultured in Dulbecco’s modified Eagle’s medium (DMEM, Gibco) 264 
 o
n
 M
ay 5, 2017 by UQ Library
http://jvi.asm.org/
D
ow
nloaded from
 
supplemented with 2mM glutamine, 100 U penicillin mL-1, 100 mg streptomycin mL-1 and 10 % 265 
fetal calf serum. Infected cells were cleared of cell debris by low-speed centrifugation (1,000 x g, 266 
30 min). Viruses were then concentrated by high-speed centrifugation (58,000 x g, 90 min) and 267 
titrated by plaque-assay on BHK-21 cells (34). 268 
Southern blotting. Viral DNA was digested with EcoR1 restriction enzyme, 269 
electrophoresed on a 0.8% agarose gel and transferred to a positively charged nylon membrane. 270 
Membrane was hybridized with 32P dCTP-labeled probes, and exposed to X-ray film.  271 
Genome sequencing. Viral genomic DNA was extracted from purified virions and full-272 
length genome sequencing was performed as described (47).  273 
Flow-cytometry. Cells were infected with WT Luc+ or gp150- Luc+ (1 PFU/cell) and 274 
incubated for 18h. Cells were incubated with MuHV-4 glycoprotein-specific mAbs (4°C, 45 275 
min). mAbs used were mAb 3F7 (anti-gN) (14), mAb TIA1 (anti-gp150) (33), and mAb 8C1 276 
(anti-gH) (48). Cells were then incubated with Alexa 633-conjugated goat anti-mouse pAb 277 
(Invitrogen) (4°C, 45 min). Cells were washed in PBS and fluorescence was analyzed on a 278 
FACSAria cytometer (Becton Dickinson). 279 
Infectious center assay. Reactivation of virus from the spleen was assayed by infectious 280 
center assay (9). Briefly, 5.105 BHK-21 cells grown in 6-wells cluster dishes were co-cultured for 281 
5 days at 37°C with ex vivo spleen cells suspension in RPMI medium containing 2 mM 282 
glutamine, 100 U penicillin ml-1, 100 mg streptomycin ml-1, 10 % fetal calf serum, 0.6% CMC 283 
and 5.10-5 M of β-mercaptoethanol. Cells were then fixed and stained for plaque counting. 284 
Quantification of anti-MuHV-4 specific antibodies by ELISA. Nunc Maxisorp ELISA 285 
plates were coated for 18h at 4°C with Triton X-100-disrupted MuHV-4 virions (106  PFU/well), 286 
blocked in PBS/0.1% Tween-20/3% BSA, and incubated with mouse sera (diluted 1/200 in 287 
PBS/0.1% Tween-20), or with mouse vaginal fluids (50 µl/well). Bound antibodies were detected 288 
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with Alkaline Phosphatase conjugated goat anti-mouse Ig polyclonal antibody (Sigma). Washing 289 
was performed with PBS/0.1% Tween-20. p-Nitrophenylphosphate (Sigma) was used as substrate 290 
for colorimetry and absorbance was read at 405 nm using a Benchmark ELISA plate reader 291 
(Thermo). 292 
Detection of infectious particles in vaginal fluids. Vaginal lavage fluids were obtained 293 
by gentle flushing the mouse vagina with 200 µl of sterile PBS. Lavage fluids were successively 294 
centrifugated (100 x g for 10 minutes and 20,000 x g for 1h30) and pellets from the two 295 
centrifugations were resuspended in 100 µl of sterile PBS. Samples were titrated on BHK-21 296 
cells by plaque-assay. 297 
Seroneutralization assay. Sera were collected one month post-infection from mice 298 
infected either with a WT Luc+ or gp150- MuHV-4. Virions were incubated with different 299 
dilutions of sera for 1h at 37°C. The virus/serum mixtures were then added to 5.105 BHK-21 cells 300 
grown in 6-wells cluster dishes, in completed DMEM medium with 0.6% CMC. Cells were 301 
cultured for 4 days before being fixed and stained for plaque counting. 302 
Viral genome quantification. MuHV-4 genomic co-ordinates 40,264-44,385were 303 
amplified (iCycler, Biorad) (gene ORF25, forward primer 5’-ATGGTATAGCCGCCTTTGTG-304 
3’, reverse primer 5’-ACAAGTGGATGAAGGGTTGC-3’). The PCR products were quantified 305 
by hybridization with a TaqMan probe (genomic co-ordinates 43,088-43,117, 5’ 6-FAM-306 
TTCATAAGTTTTATGCTGATCCAGTGGTTG-BHQ1 3’) and converted to genome copies by 307 
comparison with a standard curve of cloned plasmid template serially diluted in control spleen 308 
DNA and amplified in parallel. Cellular DNA was quantified in parallel by amplifying part of the 309 
interstitial retinoid binding protein (IRBP) gene (forward primer 5’-310 
ATCCCTATGTCATCTCCTACYTG-3’, reverse primer 5’-CCRCTGCCTTCCCATGTYTG-3’). 311 
The PCR products were quantified with Sybr green (Invitrogen), the copy number was calculated 312 
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by comparison with standard curves of cloned mouse IRBP template amplified in parallel. 313 
Amplified products were distinguished from paired primers by melting curve analysis and the 314 
correct sizes of the amplified products confirmed by electrophoresis and staining with ethidium 315 
bromide.  316 
Culture of vaginal epithelial cells. Vaginal tissues were dissected and incubated 317 
overnight at 4°C with dispase II 0.2%. Epithelial sheets were then separated from stroma, and 318 
epithelium was cut into small pieces and incubated for 30 minutes in PBS EDTA 0.01% - 319 
trypsine 0.025%. Cells were filtered on 100 µm cells stainer and cultured on fibronectin-collagen 320 
pre-coated 24-wells dishes (3.105 cells/well) as described (49). Cells were cultured in Ham’s F12 321 
medium/Dubelco’s modified eagle’s medium 1/1 (Gibco) supplemented with 2 mM glutamine, 322 
100 U penicillin ml-1, 100 mg streptomycin ml-1, 10% fetal calf serum, 2.5 µg amphotericin B ml-323 
1, 0.01 µg cholera toxin ml-1, 10 µg insulin ml-1, 10 µg transferrin ml-1, 0.4 µg hydrocortisone ml-324 
1, 10 ng murine epidermal growth factor ml-1, 50 µM beta-mercaptoethanol and 20 µg adenine 325 
ml-1.  326 
Transmission electron microscopy (TEM). Samples were prepared as previously 327 
described (19). Briefly, cells were washed with PBS and fixed directly in the dish with cacodylate 328 
buffer containing 2.5% glutaraldehyde and 2% paraformaldehyde. The cells were then scraped 329 
off and prepared for electron microscopy. Epon blocks and sections were prepared as described 330 
elsewhere (50). Sections were analyzed using a Technai Spirit transmission electron microscope 331 
(FEI, Eindhoven, The Netherlands), and electron micrographs were taken using a bottom-332 
mounted 4-by-4 K Eagle camera (FEI).  333 
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Figure Legends 479 
FIG 1 Generation of gp150- MuHV-4 expressing luciferase. (A) Two tested MuHV-4 mutations 480 
were combined. To disrupt gp150, stop codons and a EcoRI restriction site were inserted in an 481 
Afel site at genomic coordinate 69,473 (33). To express luciferase, an M3 promoter-driven 482 
cassette was inserted in a Mfe1 site at genomic coodinate 77,176 (8). (B) Viral DNA was 483 
digested with EcoRI, resolved by agarose gel electrophoresis, and hybridized with 32P-labeled 484 
probes, corresponding to nucleotides 69,467 to 70,918 (M7 open reading frame) of MuHV-4 and 485 
to the firefly luciferase coding sequence (pGL4.10, Promega). Open arrow shows the WT M7 486 
fragment (13,724 bp). Black arrows show the restriction fragments containing M7 STOP. (C) 487 
Mutants were analyzed for infected cell glycoprotein expression by flow-cytometry. We used 488 
monoclonal antibodies recognizing gp150 (T1A1), gH (8C1) and gN (3F7) (14, 15, 48). 489 
 490 
FIG 2 Bioluminescent imaging of gp150- MuHV-4. (A) Female mice were infected intranasally 491 
with gp150+ or gp150- Luc MuHV-4 (104 PFU under general anesthesia) and imaged at the 492 
times indicated. (B) Representative images are shown for each group at days 7, 14 and 17-21 p.i.. 493 
(C) Signal intensities were compared for each organ (n=20 mice per group), measuring 494 
equivalent regions of interest and subtracting the right abdominal signal as a negative 495 
background. 102 p/s/cm2/sr which is the limit of detection of the assay. Results were analyzed by 496 
linear model, using day post-infection, strain and interaction between day and strain as factors; 497 
p>0.05 for all comparisons, except for the SCLN, where gp150- signals were significantly higher 498 
at days 7, 14 and 17 (* p<0.05, *** p<0.001). (D-E) To assay genital tract colonization, mice 499 
were imaged every day from 17 to 21 days p.i.. Positive signals were taken as those >2 standard 500 
deviations above the mean of 10 uninfected mice (threshold represented by the dashed line). 501 
Occurrence of genital signal (D, n=40 mice per group) and maximal genital signal (E, n=20 mice 502 
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per group) showed no significant difference between the groups (p>0.05 by Chi2 and Mann 503 
Whitney tests respectively). (F) The smallest pieces of genital tissue expressing luciferase were 504 
isolated. Genome copy numbers were then measured by qPCR and did not show a significant 505 
difference between groups (n=20 mice per group, p>0.05 by Mann Whitney test). The histograms 506 
show mean values. Dpi: days post-infection. i.n.: intranasal. The results are representative of 507 
three independent experiments.  508 
 509 
FIG 3 Seroconversion and latency establishment after intranasal inoculation of gp150+ and 510 
gp150- MuHV-4. Female mice were infected intranasally with WT or gp150- MuHV-4 (104 PFU 511 
under general anesthesia). At 1 month p.i., sera and spleen were collected. (A) ELISA of sera 512 
showed no difference in MuHV-4 specific antibody between the groups (p>0.05 by ANOVA I 513 
and Bonferroni post-hoc test). (B) Viral genome copy numbers in spleen measured by qPCR 514 
showed no significant difference between the groups (p>0.05 by ANOVA I and Bonferroni post-515 
hoc test). (C) Nor did infectious center assays of spleens show a difference between the groups 516 
(p>0.05 by Student test). Mean values are represented by histograms.  517 
 518 
FIG 4 Gp150 promotes MuHV-4 sexual transmission. Female BALB/c mice were infected 519 
intranasally with gp150+ or gp150- MuHV-4 (104 PFU under general anesthesia) and imaged at 520 
the indicated times. When genital signal appeared, they were mated with naive BALB/c males, 521 
which were then monitored in turn by IVIS. (A) Experimental scheme. (B-C) Occurrence of 522 
positive genital signal (B) and maximal genital signals (C) in males, imaged between 3 and 21 523 
days post-contact with females. Signal intensities were measured in equivalent regions of interest, 524 
subtracting the right abdominal region as background. Males with a genital signal >2 standard 525 
deviations above the mean of 10 controls (the dotted line in C) were considered positive (n=6 in 526 
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C; p<0.05 by Fisher test). B shows pooled data for 2 experiments (p<0.01 by Fisher test). C 527 
shows 1 experiment (20 mice per group). (D-E) Male infections were confirmed at 1 month by 528 
ELISA of serum for MuHV-4-specific Ig (D), qPCR of splenic viral genome loads (E) and 529 
infectious center assay of spleens (F). dpc: days post-contact. D, E and F all show significant 530 
differences by Fisher test (p<0.05). 531 
 532 
FIG 5 MuHV-4 infection of male genital mucosa. Male BALB/c mice (n=15 per group) were 533 
infected under general anesthesia, by scraping virions (105 PFU) on the penile mucosa. Animals 534 
were imaged for 8 consecutive days. (A) Maximal genital signal observed for each male by in 535 
vivo imaging between days 1 and 8 p.i. (p>0.05 by Fisher test). (B) Images show a representative 536 
positive mouse from each group.   537 
 538 
FIG 6 Importance of gp150 for protection against neutralizing antibodies. (A) Female BALB/c 539 
mice were infected intranasally with gp150+ or gp150- MuHV-4 (104 PFU under general 540 
anesthesia) and vaginal fluids collected at day 24 p.i. were tested by ELISA for MuHV-4-specific 541 
antibodies. No difference was observed between the groups (p>0.05 by Fisher test). (B) Gp150+ 542 
and gp150- virions (200 PFU) were incubated (1h, 37°C) with dilutions of sera from BALB/c 543 
mice infected 1 month previously with the same viruses. After incubation, the virus/serum 544 
mixtures were plaque-assayed on BHK-21 cells. Titers are expressed relative to virus without 545 
antibody. The data show averages of triplicate measurements +/- standard error of the mean and 546 
were analyzed by two-way ANOVA and Bonferroni post-hoc tests. No significant difference was 547 
observed (p>0.05), except at one dilution of serum, where gp150+ virions were significantly 548 
more neutralized by gp150+ MuHV-4-elicited antibody (** p<0.01). 549 
 550 
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FIG 7 Defective gp150 virion release from vaginal epithelial cells. (A) Female BALB/c mice 551 
were infected intranasally with gp150+ or gp150- MuHV-4 (104 PFU under general anesthesia) 552 
and serially imaged by IVIS. When genital signal appeared, vaginal fluids were collected by 553 
lavage. Cell-associated and cell-free virions were separated by successive centrifugations. Each 554 
was quantified by plaque assay. Results were analyzed by Mann Withney test (ns, p>0.05; *** 555 
p<0.001). (B) Primary vaginal epithelial cells were infected with gp150- or gp150+ MuHV-4 556 
(0.05 PFU/cell). Supernatants and cells were collected and plaque-assayed on BHK-21 cells. 557 
Results were analyzed by two-way ANOVA and Bonferroni post-hoc tests (**, p<0.01; ***, 558 
p<0.001). (C) Primary vaginal epithelial cells were infected with gp150- or gp150+ MuHV-4 (1 559 
PFU / cell, 18h) then stained for gN. Staining of fixed and permeabilized cells was used to assess 560 
total infection, while staining of intact cells was used to estimate virion numbers at the cell 561 
surface. (gM/gN homes strongly to the Golgi nertwork, and so reaches the cell surface only by 562 
virtue of incorporation into virions (14).) Mean fluorescence intensities (MFI) were analyzed by 563 
one-way ANOVA and Bonferroni post-hoc tests (ns, p>0.05; *** p<0.001). These results are 564 
representative of at least 3 experiments. (D) Primary vaginal cells were infected with gp150+ or 565 
gp150- MuHV-4 (2 PFU / cell). 48h p.i., cells were stained for gN, counterstained with DAPI and 566 
observed by confocal microscopy. (E) Primary vaginal cells were infected with gp150+ or gp150- 567 
MuHV-4 (1 PFU / cell) and then processed for TEM. The pictures are representative of at least 568 
10 sections per sample: (i) and (ii) are from 24h p.i.; (iii) and (iv) are from 48h p.i.. 569 
 570 
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